Literature DB >> 24862346

Cystic fibrosis sputum DNA has NETosis characteristics and neutrophil extracellular trap release is regulated by macrophage migration-inhibitory factor.

Markryan Dwyer1, Qiang Shan, Samantha D'Ortona, Rie Maurer, Robert Mitchell, Hanne Olesen, Steffen Thiel, Johannes Huebner, Mihaela Gadjeva.   

Abstract

Neutrophils are the main proinflammatory cell type in chronically infected lungs of cystic fibrosis (CF) patients; however, they fail to effectively clear the colonizing pathogens. Here, we investigated the molecular composition of non-mucoid and mucoid Pseudomonas aeruginosa-induced neutrophil extracellular traps (NETs) in vitro and compared them to the DNA-protein complexes present in the CF sputum. The protein composition of P. aeruginosa-induced NET fragments revealed that irrespective of the inducing stimuli, NET fragments were decorated with a conserved set of proteins. The DNA-protein complexes derived from CF sputum were consistent with NETosis and shared a similar protein signature, suggesting that the majority of the extracellular DNA was NET derived. The ability of polymorphonuclear leukocytes to produce NETs in response to P. aeruginosa was driven by macrophage migration-inhibitory factor (MIF) by promoting mitogen-activated protein kinase. Analysis of 132 CF patient samples revealed that elevated MIF protein levels correlated with poorer lung function. We suggest that targeting MIF by small molecular inhibitors might reduce the presence of extracellular DNA and serve as an adjunct to the use of antimicrobial drugs that could ultimately reduce bacterial fitness in the lungs during the later stages of CF disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24862346      PMCID: PMC4201867          DOI: 10.1159/000363242

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  39 in total

1.  A functional heteromeric MIF receptor formed by CD74 and CXCR4.

Authors:  Verena Schwartz; Hongqi Lue; Sandra Kraemer; Joanna Korbiel; Regina Krohn; Kim Ohl; Richard Bucala; Christian Weber; Jürgen Bernhagen
Journal:  FEBS Lett       Date:  2009-08-06       Impact factor: 4.124

2.  Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.

Authors:  Alice V Dubois; Alexandre Gauthier; Déborah Bréa; Françoise Varaigne; Patrice Diot; Francis Gauthier; Sylvie Attucci
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-16       Impact factor: 6.914

3.  Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism.

Authors:  Barry J Plant; Charles G Gallagher; Richard Bucala; John A Baugh; Sally Chappell; Linda Morgan; Clare M O'Connor; Kevin Morgan; Seamas C Donnelly
Journal:  Am J Respir Crit Care Med       Date:  2005-09-22       Impact factor: 21.405

4.  DNase I acutely increases cystic fibrosis sputum elastase activity and its potential to induce lung hemorrhage in mice.

Authors:  A M Cantin
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

5.  DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha.

Authors:  F Ratjen; K Paul; S van Koningsbruggen; S Breitenstein; E Rietschel; W Nikolaizik
Journal:  Pediatr Pulmonol       Date:  2005-01

6.  Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.

Authors:  G Hansen; S Hoffjan; K Mosler; A Schuster
Journal:  Lung       Date:  2002-02-04       Impact factor: 2.584

7.  Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway.

Authors:  Ralf Baumann; Carmen Casaulta; Dagmar Simon; Sébastien Conus; Shida Yousefi; Hans-Uwe Simon
Journal:  FASEB J       Date:  2003-12       Impact factor: 5.191

8.  IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival.

Authors:  Inbal Binsky; Michal Haran; Diana Starlets; Yael Gore; Frida Lantner; Nurit Harpaz; Lin Leng; David M Goldenberg; Lev Shvidel; Alain Berrebi; Richard Bucala; Idit Shachar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-08       Impact factor: 11.205

9.  Global substrate profiling of proteases in human neutrophil extracellular traps reveals consensus motif predominantly contributed by elastase.

Authors:  Anthony J O'Donoghue; Ye Jin; Giselle M Knudsen; Natascha C Perera; Dieter E Jenne; John E Murphy; Charles S Craik; Terry W Hermiston
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

10.  Activation of PAD4 in NET formation.

Authors:  Amanda S Rohrbach; Daniel J Slade; Paul R Thompson; Kerri A Mowen
Journal:  Front Immunol       Date:  2012-11-29       Impact factor: 7.561

View more
  74 in total

1.  Neutrophil extracellular traps in COVID-19.

Authors:  Yu Zuo; Srilakshmi Yalavarthi; Hui Shi; Kelsey Gockman; Melanie Zuo; Jacqueline A Madison; Christopher Blair; Andrew Weber; Betsy J Barnes; Mikala Egeblad; Robert J Woods; Yogendra Kanthi; Jason S Knight
Journal:  JCI Insight       Date:  2020-06-04

2.  Chelation of Membrane-Bound Cations by Extracellular DNA Activates the Type VI Secretion System in Pseudomonas aeruginosa.

Authors:  Mike Wilton; Megan J Q Wong; Le Tang; Xiaoye Liang; Richard Moore; Michael D Parkins; Shawn Lewenza; Tao G Dong
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

Review 3.  Neutrophil extracellular traps: a walk on the wild side of exercise immunology.

Authors:  Thomas Beiter; Annunziata Fragasso; Dominik Hartl; Andreas M Nieß
Journal:  Sports Med       Date:  2015-05       Impact factor: 11.136

Review 4.  Neutrophil Extracellular Traps in the Second Decade.

Authors:  Volker Brinkmann
Journal:  J Innate Immun       Date:  2018-06-15       Impact factor: 7.349

Review 5.  Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.

Authors:  Laurent Meijer; Deborah J Nelson; Vladimir Riazanski; Aida G Gabdoulkhakova; Geneviève Hery-Arnaud; Rozenn Le Berre; Nadège Loaëc; Nassima Oumata; Hervé Galons; Emmanuel Nowak; Laetitia Gueganton; Guillaume Dorothée; Michaela Prochazkova; Bradford Hall; Ashok B Kulkarni; Robert D Gray; Adriano G Rossi; Véronique Witko-Sarsat; Caroline Norez; Frédéric Becq; Denis Ravel; Dominique Mottier; Gilles Rault
Journal:  J Innate Immun       Date:  2016-03-18       Impact factor: 7.349

6.  Gone with the Wind--Innate Immunity and Airway Inflammation.

Authors:  Heiko Herwald; Arne Egesten
Journal:  J Innate Immun       Date:  2016-03-01       Impact factor: 7.349

Review 7.  Neutrophil extracellular traps in immunity and disease.

Authors:  Venizelos Papayannopoulos
Journal:  Nat Rev Immunol       Date:  2017-10-09       Impact factor: 53.106

8.  Distinct susceptibilities of corneal Pseudomonas aeruginosa clinical isolates to neutrophil extracellular trap-mediated immunity.

Authors:  Qiang Shan; Markryan Dwyer; Samir Rahman; Mihaela Gadjeva
Journal:  Infect Immun       Date:  2014-07-21       Impact factor: 3.441

9.  The role for neutrophil extracellular traps in cystic fibrosis autoimmunity.

Authors:  Sladjana Skopelja; B JoNell Hamilton; Jonathan D Jones; Mei-Ling Yang; Mark Mamula; Alix Ashare; Alex H Gifford; William Fc Rigby
Journal:  JCI Insight       Date:  2016-10-20

10.  Neutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epithelia.

Authors:  Kristin M Hudock; Margaret S Collins; Michelle Imbrogno; John Snowball; Elizabeth L Kramer; John J Brewington; Kandace Gollomp; Cormac McCarthy; Alicia J Ostmann; Elizabeth J Kopras; Cynthia R Davidson; Anusha Srdiharan; Paritha Arumugam; Shaon Sengupta; Yan Xu; G Scott Worthen; Bruce C Trapnell; John Paul Clancy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-11       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.